Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongjun Bai

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Journal of Virology|June 23, 2021
Limited Evidence for a Relationship between HIV-1 Glycan Shield Features in Early Infection and the Development of Neutralization BreadthYifan Li, Hongjun Bai, Eric Sanders-Buell, et al.
Journal of the International AIDS Society|August 29, 2025
High peak viraemia followed by spontaneous HIV-1 control in women living with HIV-1 subtype A1 in East AfricaYifan Li, Bethany L Dearlove, Eric Lewitus, et al.
Plos Pathogens|March 18, 2022
HIV-1 infections with multiple founders associate with the development of neutralization breadthEric Lewitus, Samantha M Townsley, Yifan Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 30, 2025
SIV monoclonal antibody administration spanning treatment interruption in macaques delays viral rebound and selects escape variantsHannah A D King, Daniel Brammer, Eric Lewitus, et al.
Nature Communications|May 9, 2024
Contemporary HIV-1 consensus Env with AI-assisted redesigned hypervariable loops promote antibody bindingHongjun Bai, Eric Lewitus, Yifan Li, et al.
Ebiomedicine|September 11, 2022
Long-term antiretroviral therapy initiated in acute HIV infection prevents residual dysfunction of HIV-specific CD8<sup>+</sup> T cellsHiroshi Takata, Juyeon C Kakazu, Julie L Mitchell, et al.
Virus Evolution|October 10, 2024
SARS-CoV-2 variant replacement constrains vaccine-specific viral diversificationBethany L Dearlove, Anthony C Fries, Nusrat J Epsi, et al.
The Journal of Clinical Investigation|March 18, 2020
Neutralizing antibody VRC01 failed to select for HIV-1 mutations upon viral reboundEvan M Cale, Hongjun Bai, Meera Bose, et al.
Journal of Virology|July 3, 2023
Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus ActivityJaime L Jensen, Rajeshwer S Sankhala, Vincent Dussupt, et al.
Research Square|July 3, 2023
Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence featuresCraig Magaret, Li Li, Allan deCamp, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Journal of Virology|June 23, 2021
Limited Evidence for a Relationship between HIV-1 Glycan Shield Features in Early Infection and the Development of Neutralization BreadthYifan Li, Hongjun Bai, Eric Sanders-Buell, et al.
Journal of the International AIDS Society|August 29, 2025
High peak viraemia followed by spontaneous HIV-1 control in women living with HIV-1 subtype A1 in East AfricaYifan Li, Bethany L Dearlove, Eric Lewitus, et al.
Plos Pathogens|March 18, 2022
HIV-1 infections with multiple founders associate with the development of neutralization breadthEric Lewitus, Samantha M Townsley, Yifan Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 30, 2025
SIV monoclonal antibody administration spanning treatment interruption in macaques delays viral rebound and selects escape variantsHannah A D King, Daniel Brammer, Eric Lewitus, et al.
Nature Communications|May 9, 2024
Contemporary HIV-1 consensus Env with AI-assisted redesigned hypervariable loops promote antibody bindingHongjun Bai, Eric Lewitus, Yifan Li, et al.
Ebiomedicine|September 11, 2022
Long-term antiretroviral therapy initiated in acute HIV infection prevents residual dysfunction of HIV-specific CD8<sup>+</sup> T cellsHiroshi Takata, Juyeon C Kakazu, Julie L Mitchell, et al.
Virus Evolution|October 10, 2024
SARS-CoV-2 variant replacement constrains vaccine-specific viral diversificationBethany L Dearlove, Anthony C Fries, Nusrat J Epsi, et al.
The Journal of Clinical Investigation|March 18, 2020
Neutralizing antibody VRC01 failed to select for HIV-1 mutations upon viral reboundEvan M Cale, Hongjun Bai, Meera Bose, et al.
Journal of Virology|July 3, 2023
Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus ActivityJaime L Jensen, Rajeshwer S Sankhala, Vincent Dussupt, et al.
Research Square|July 3, 2023
Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence featuresCraig Magaret, Li Li, Allan deCamp, et al.
Pageof 5